Somatic Ret Indels In Sporadic Medullary Thyroid Cancer: Prevalence And Response To Selpercatinib. Elisei R, Ciampi R, Matrone A, Prete A, et al. J Clin Endocrinol Metab 2022 May 25. pii: 6591888. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Elisei R, Ciampi R, Matrone A, Prete A, et al. Somatic Ret Indels In Sporadic Medullary Thyroid Cancer: Prevalence And Response To Selpercatinib. J Clin Endocrinol Metab 2022 May 25. pii: 6591888. doi: 10.1210.
PMID: 35616103